Page last updated: 2024-11-12

bis(pyridine)iodonium(i) tetrafluoroborate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bis(pyridine)iodonium(I) tetrafluoroborate: an iodinating reagent for peptides [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10883201
MeSH IDM0500558

Synonyms (18)

Synonym
A809756
FT-0623094
AKOS015892160
bis(pyridine)iodonium(i)tetrafluoroborate
bis(pyridine)iodonium (i) tetrafluoroborate
bis(pyridine)iodonium(i) tetrafluoroborate
bis(pyridin)iodonium tetrafluoroborate
bispyridine iodonium tetrafluoroborate
WVXJCTSZJWIBQT-UHFFFAOYSA-N
bis(pyridine)-iodonium tetrafluoroborate
DTXSID50447027
mfcd03703393
J-009311
iodanium;pyridine;tetrafluoroborate
bis(pyridine)iodonium tetrafluoroborate [barluenga's reagent]
FS-5769
MS-20133
AKOS040768511
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.20

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.20 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.20)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]